The Goldman Sachs Group has entered into an agreement to acquire Industry Ventures, a leading venture capital platform that invests in businesses and funds across all stages of the venture capital ...

Funding through the third quarter surpassed last year’s total, according to PitchBook. Meanwhile, average deal sizes are ...

On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving it can go toe-to-toe with the other investor, closing a VC fund of "more than $3 billion." The ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Two Silicon Valley venture capitalists are creating a new venture capital ...

In its 53-year history, Sofinnova Partners has invested in more than 500 companies. The venture capital firm now has €1.2 billion to invest in more. The additional funds have come at a fast clip.

Like other growth industries, many of its boosters stand to get rich. More than others, though, life sciences champions credibly claim their businesses can save lives. Even better to thrill local flag ...

The global venture capital market clawed back some momentum in the second quarter of 2025, though structural weaknesses, especially in fundraising, continued to cast a long shadow. That’s according to ...

SAN FRANCISCO (Reuters) - Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have each raised or are raising funds this ...

This week on StrictlyVC Download, TechCrunch Editor-in-Chief Connie Loizos talks with Uncork Capital’s Jeff Clavier and Andy McLoughlin. They discuss how their seed-stage firm is positioning itself in ...

HUNTINGTON BEACH, Calif.--With the war in Iraq, reconstruction after Hurricane Katrina and skyrocketing gas prices all signaling a weak economy, one might assume that today presents a poor landscape ...

The life sciences industry is fueled by innovation, knowledge and insight. Thriving companies within this industry, whether biotechnology, pharmaceuticals, medical devices, diagnostics or research ...